English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 24 January 2020, 12:00 HKT/SGT
Share:
New Disinfectant Stops Spread of Virus, Including Coronavirus Strain from China

SYDNEY, Jan 24, 2020 - (ACN Newswire) - Australian researcher Steven Kritzler says his Evocide Extra disinfectant is able to stop the spread of virus, as in the present outbreak in Wuhan City, China. This new strain of Coronavirus is a SARS-like virus that has caused hundreds of infections in China, and has spread to Thailand, Japan and South Korea.


Steven Kritzler of Novapharm Research (Aus) Pty. Ltd.


"Both the Wuhan virus, known as 2019-nCoV, and SARS belong to the family of viruses known as Coronaviridae, which can be deactivated by many materials, such as Evocide Extra," says Kritzler, who is based at Novapharm Research near Sydney, and is a committee member of the Australian Therapeutic Goods Administration (TGA).

Kritzler garnered attention at the Symposium on Advanced Infection Control in November when his Evocide Extra disinfectant formulation was presented. "Coronavirus is a type of enveloped virus -- a virus that develops viruses. My formulation can deactivate any virus, including enveloped and non-enveloped viruses."

"Coronavirus is microscopic, hence face masks alone cannot effectively prevent spreading the virus. I suggest that the best way to protect from spreading the virus is to wash your hands regularly, for example when you touch the door handle. And remember to use the disinfectants in time," says Kritzler.

Southern Cross, another formulation by Kritzler, are eco-friendly skin and hard surface disinfectant paper wipes that can deactivate viruses such as HIV (human immunodeficiency virus), hand-foot-mouth (EV71), influenza A (H1N1) and measles, and like Evocide can kill 99.999% of bacterial pathogens including super bacteria.

The Chinese Spring Festival holiday begins later this week, increasing the risk of spread of the new virus. The holiday period typically sees hundreds of millions of Chinese traveling throughout the country and overseas.

Contact: Kenny Kang, [email protected]
Southern Cross Biotechnology Pty Ltd.

Topic: Press release summary
Sectors: Environment, HealthCare
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Mitsubishi Chemical:Has developed new electrolyte for Tesla. The solvents and solute are supplied from Shida Shenghua  
Sept 20, 2020 13:13 HKT/SGT
The REL Token is Listed on CoinsBit and AzBit Cryptocurrency Exchanges. We, Release Project, Will Transform the Logistics of Agriculture and Fisheries Around the World  
Sept 18, 2020 19:00 HKT/SGT
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance  
Sept 18, 2020 17:00 HKT/SGT
Tiger Brokers adds ASX to its Online Trading & Mobile App  
Sept 18, 2020 13:30 HKT/SGT
MITSUBISHI MOTORS Redesigns New ECLIPSE CROSS, Also Offered with Plug-in Hybrid Powertrain  
Sept 18, 2020 11:09 HKT/SGT
Eisai Presents Latest Data of Phase I Clinical Trial on Liposomal Formulation of Anti-Cancer Agent Halaven (Eribulin) at ESMO Virtual Congress 2020  
Sept 18, 2020 10:29 HKT/SGT
AVIA Hosts the Satellite Industry Forum Focusing on Video in the Satellite World  
Sept 18, 2020 10:00 HKT/SGT
Fujitsu Develops Technology to Block Facial Authentication Fraud  
Sept 18, 2020 09:20 HKT/SGT
TAITRA's Smart Manufacturing Webinar a Success, Captures Worldwide Buyer Attention  
Sept 18, 2020 09:00 HKT/SGT
DoiT Signs Multi-Year, Strategic, Non-Binding 1.5 Billion Dollar Agreement with Google Cloud  
Sept 17, 2020 21:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575